Kelly CRISPR & Gene Editing Technology ETF (XDNA) — ETF Analysis on Winston

Key Facts

• Issuer: KellyETFs
• Category: Equity
• Asset Class: Equity
• Price: $7.38
• Expense Ratio: 78.00%
• Assets Under Management: $3M
• Number of Holdings: 1
• Inception Date: 2022-01-13
• Currency: USD

Winston Score

Kelly CRISPR & Gene Editing Technology ETF has a Winston Score of 46 out of 100.

Sector Breakdown

Healthcare (N/A%)